Long-term Patiromer Use and Outcomes Among US Veterans With Hyperkalemia and CKD: A Propensity-Matched Cohort Study

Long-term Patiromer Use and Outcomes Among US Veterans With Hyperkalemia and CKD: A Propensity-Matched Cohort Study

Rationale & Objective: Patiromer is a potassium binder approved for the long-term management of hyperkalemia. Although patiromer use among patients with advanced chronic kidney disease (CKD) has been shown to reduce the discontinuation of renin-angiotensin-aldosterone system inhibition thera...

Full description

Bibliographic Details
Main Authors: Yoshitsugu Obi, Fridtjof Thomas, Ankur A. Dashputre, Patricia Goedecke, Csaba P. Kovesdy
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Kidney Medicine
Subjects:
Chronic kidney disease
end-stage kidney disease
hyperkalemia
mortality
patiromer
Online Access:http://www.sciencedirect.com/science/article/pii/S2590059523001759

Similar Items

Similar Items